Cargando…

Corona Virus Disease-19 serology, inflammatory markers, hospitalizations, case finding, and aging

Most deaths from severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection occur in older subjects. We assessed the utility of serum inflammatory markers interleukin-6 (IL-6), C reactive protein (CRP), and ferritin (Roche, Indianapolis, IN), and SARS-CoV-2 immunoglobulin G (IgG), immuno...

Descripción completa

Detalles Bibliográficos
Autores principales: Schaefer, Ernst J., Dulipsingh, Latha, Comite, Florence, Jimison, Jessica, Grajower, Martin M., Lebowitz, Nathan E., Lang, Maxine, Geller, Andrew S., Diffenderfer, Margaret R., He, Lihong, Breton, Gary, Dansinger, Michael L., Saida, Ben, Yuan, Chong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8191995/
https://www.ncbi.nlm.nih.gov/pubmed/34111164
http://dx.doi.org/10.1371/journal.pone.0252818
_version_ 1783705964646498304
author Schaefer, Ernst J.
Dulipsingh, Latha
Comite, Florence
Jimison, Jessica
Grajower, Martin M.
Lebowitz, Nathan E.
Lang, Maxine
Geller, Andrew S.
Diffenderfer, Margaret R.
He, Lihong
Breton, Gary
Dansinger, Michael L.
Saida, Ben
Yuan, Chong
author_facet Schaefer, Ernst J.
Dulipsingh, Latha
Comite, Florence
Jimison, Jessica
Grajower, Martin M.
Lebowitz, Nathan E.
Lang, Maxine
Geller, Andrew S.
Diffenderfer, Margaret R.
He, Lihong
Breton, Gary
Dansinger, Michael L.
Saida, Ben
Yuan, Chong
author_sort Schaefer, Ernst J.
collection PubMed
description Most deaths from severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection occur in older subjects. We assessed the utility of serum inflammatory markers interleukin-6 (IL-6), C reactive protein (CRP), and ferritin (Roche, Indianapolis, IN), and SARS-CoV-2 immunoglobulin G (IgG), immunoglobulin M (IgM), and neutralizing antibodies (Diazyme, Poway, CA). In controls, non-hospitalized subjects, and hospitalized subjects assessed for SARS-CoV-2 RNA (n = 278), median IgG levels in arbitrary units (AU)/mL were 0.05 in negative subjects, 14.83 in positive outpatients, and 30.61 in positive hospitalized patients (P<0.0001). Neutralizing antibody levels correlated significantly with IgG (r = 0.875; P<0.0001). Having combined values of IL-6 ≥10 pg/mL and CRP ≥10 mg/L occurred in 97.7% of inpatients versus 1.8% of outpatients (odds ratio 3,861, C statistic 0.976, P = 1.00 x 10(−12)). Antibody or ferritin levels did not add significantly to predicting hospitalization. Antibody testing in family members and contacts of SARS-CoV-2 RNA positive cases (n = 759) was invaluable for case finding. Persistent IgM levels were associated with chronic COVID-19 symptoms. In 81,624 screened subjects, IgG levels were positive (≥1.0 AU/mL) in 5.21%, while IgM levels were positive in 2.96% of subjects. In positive subjects median IgG levels in AU/mL were 3.14 if <30 years of age, 4.38 if 30–44 years of age, 7.89 if 45–54 years of age, 9.52 if 55–64 years of age, and 10.64 if ≥65 years of age (P = 2.96 x 10(−38)). Our data indicate that: 1) combined IL-6 ≥10 pg/mL and CRP ≥10 mg/L identify SARS-CoV-2 positive subjects requiring hospitalization; 2) IgG levels were significantly correlated with neutralizing antibody levels with a wide range of responses; 3) IgG levels have significant utility for case finding in exposed subjects; 4) persistently elevated IgM levels are associated with chronic symptoms; and 5) IgG levels are significantly higher in positive older subjects than their younger counterparts.
format Online
Article
Text
id pubmed-8191995
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-81919952021-06-10 Corona Virus Disease-19 serology, inflammatory markers, hospitalizations, case finding, and aging Schaefer, Ernst J. Dulipsingh, Latha Comite, Florence Jimison, Jessica Grajower, Martin M. Lebowitz, Nathan E. Lang, Maxine Geller, Andrew S. Diffenderfer, Margaret R. He, Lihong Breton, Gary Dansinger, Michael L. Saida, Ben Yuan, Chong PLoS One Research Article Most deaths from severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection occur in older subjects. We assessed the utility of serum inflammatory markers interleukin-6 (IL-6), C reactive protein (CRP), and ferritin (Roche, Indianapolis, IN), and SARS-CoV-2 immunoglobulin G (IgG), immunoglobulin M (IgM), and neutralizing antibodies (Diazyme, Poway, CA). In controls, non-hospitalized subjects, and hospitalized subjects assessed for SARS-CoV-2 RNA (n = 278), median IgG levels in arbitrary units (AU)/mL were 0.05 in negative subjects, 14.83 in positive outpatients, and 30.61 in positive hospitalized patients (P<0.0001). Neutralizing antibody levels correlated significantly with IgG (r = 0.875; P<0.0001). Having combined values of IL-6 ≥10 pg/mL and CRP ≥10 mg/L occurred in 97.7% of inpatients versus 1.8% of outpatients (odds ratio 3,861, C statistic 0.976, P = 1.00 x 10(−12)). Antibody or ferritin levels did not add significantly to predicting hospitalization. Antibody testing in family members and contacts of SARS-CoV-2 RNA positive cases (n = 759) was invaluable for case finding. Persistent IgM levels were associated with chronic COVID-19 symptoms. In 81,624 screened subjects, IgG levels were positive (≥1.0 AU/mL) in 5.21%, while IgM levels were positive in 2.96% of subjects. In positive subjects median IgG levels in AU/mL were 3.14 if <30 years of age, 4.38 if 30–44 years of age, 7.89 if 45–54 years of age, 9.52 if 55–64 years of age, and 10.64 if ≥65 years of age (P = 2.96 x 10(−38)). Our data indicate that: 1) combined IL-6 ≥10 pg/mL and CRP ≥10 mg/L identify SARS-CoV-2 positive subjects requiring hospitalization; 2) IgG levels were significantly correlated with neutralizing antibody levels with a wide range of responses; 3) IgG levels have significant utility for case finding in exposed subjects; 4) persistently elevated IgM levels are associated with chronic symptoms; and 5) IgG levels are significantly higher in positive older subjects than their younger counterparts. Public Library of Science 2021-06-10 /pmc/articles/PMC8191995/ /pubmed/34111164 http://dx.doi.org/10.1371/journal.pone.0252818 Text en © 2021 Schaefer et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Schaefer, Ernst J.
Dulipsingh, Latha
Comite, Florence
Jimison, Jessica
Grajower, Martin M.
Lebowitz, Nathan E.
Lang, Maxine
Geller, Andrew S.
Diffenderfer, Margaret R.
He, Lihong
Breton, Gary
Dansinger, Michael L.
Saida, Ben
Yuan, Chong
Corona Virus Disease-19 serology, inflammatory markers, hospitalizations, case finding, and aging
title Corona Virus Disease-19 serology, inflammatory markers, hospitalizations, case finding, and aging
title_full Corona Virus Disease-19 serology, inflammatory markers, hospitalizations, case finding, and aging
title_fullStr Corona Virus Disease-19 serology, inflammatory markers, hospitalizations, case finding, and aging
title_full_unstemmed Corona Virus Disease-19 serology, inflammatory markers, hospitalizations, case finding, and aging
title_short Corona Virus Disease-19 serology, inflammatory markers, hospitalizations, case finding, and aging
title_sort corona virus disease-19 serology, inflammatory markers, hospitalizations, case finding, and aging
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8191995/
https://www.ncbi.nlm.nih.gov/pubmed/34111164
http://dx.doi.org/10.1371/journal.pone.0252818
work_keys_str_mv AT schaeferernstj coronavirusdisease19serologyinflammatorymarkershospitalizationscasefindingandaging
AT dulipsinghlatha coronavirusdisease19serologyinflammatorymarkershospitalizationscasefindingandaging
AT comiteflorence coronavirusdisease19serologyinflammatorymarkershospitalizationscasefindingandaging
AT jimisonjessica coronavirusdisease19serologyinflammatorymarkershospitalizationscasefindingandaging
AT grajowermartinm coronavirusdisease19serologyinflammatorymarkershospitalizationscasefindingandaging
AT lebowitznathane coronavirusdisease19serologyinflammatorymarkershospitalizationscasefindingandaging
AT langmaxine coronavirusdisease19serologyinflammatorymarkershospitalizationscasefindingandaging
AT gellerandrews coronavirusdisease19serologyinflammatorymarkershospitalizationscasefindingandaging
AT diffenderfermargaretr coronavirusdisease19serologyinflammatorymarkershospitalizationscasefindingandaging
AT helihong coronavirusdisease19serologyinflammatorymarkershospitalizationscasefindingandaging
AT bretongary coronavirusdisease19serologyinflammatorymarkershospitalizationscasefindingandaging
AT dansingermichaell coronavirusdisease19serologyinflammatorymarkershospitalizationscasefindingandaging
AT saidaben coronavirusdisease19serologyinflammatorymarkershospitalizationscasefindingandaging
AT yuanchong coronavirusdisease19serologyinflammatorymarkershospitalizationscasefindingandaging